These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7589829)

  • 1. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM.
    Klein HH; Vestergaard H; Kotzke G; Pedersen O
    Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.
    Worm D; Vinten J; Staehr P; Henriksen JE; Handberg A; Beck-Nielsen H
    Diabetologia; 1996 Oct; 39(10):1208-14. PubMed ID: 8897009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
    Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
    Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
    Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
    Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy.
    Denne SC; Brechtel G; Johnson A; Liechty EA; Baron AD
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2371-7. PubMed ID: 7629232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
    Zierath JR; He L; Gumà A; Odegoard Wahlström E; Klip A; Wallberg-Henriksson H
    Diabetologia; 1996 Oct; 39(10):1180-9. PubMed ID: 8897005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin activation of insulin receptor kinase in erythrocytes is not altered in non-insulin-dependent diabetes and not influenced by hyperglycemia.
    Klein HH; Müller R; Drenckhan M; Schütt M; Bätge B; Fehm HL
    J Endocrinol; 2000 Aug; 166(2):275-81. PubMed ID: 10927617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
    Björnholm M; Kawano Y; Lehtihet M; Zierath JR
    Diabetes; 1997 Mar; 46(3):524-7. PubMed ID: 9032113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
    Nolan JJ; Ludvik B; Baloga J; Reichart D; Olefsky JM
    Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans.
    Nyomba BL; Ossowski VM; Bogardus C; Mott DM
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E964-74. PubMed ID: 2163202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
    Ferri C; Carlomagno A; Coassin S; Baldoncini R; Cassone Faldetta MR; Laurenti O; Properzi G; Santucci A; De Mattia G
    Diabetes Care; 1995 Feb; 18(2):226-33. PubMed ID: 7729302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects.
    Krook A; Roth RA; Jiang XJ; Zierath JR; Wallberg-Henriksson H
    Diabetes; 1998 Aug; 47(8):1281-6. PubMed ID: 9703329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.